侯雅楠证券分析师SAC No:S1150524120001行业要闻(1)国家医疗保障局印发《手术和治疗辅助操作类医疗服务价格项目立项指南(试行)》;(2)商务部等九部门发布关于促进药品零售行业高质量发展的意见;(3)替尔泊肽拟纳入突破性疗法,治疗代谢相关性脂肪性肝病。公司公告(1)恒瑞医药:获得药物临床试验批准通知书;(2)百利天恒:iza-bren用于治疗复发性或转移性食管鳞癌的药品上市申请获得...
Source Link侯雅楠证券分析师SAC No:S1150524120001行业要闻(1)国家医疗保障局印发《手术和治疗辅助操作类医疗服务价格项目立项指南(试行)》;(2)商务部等九部门发布关于促进药品零售行业高质量发展的意见;(3)替尔泊肽拟纳入突破性疗法,治疗代谢相关性脂肪性肝病。公司公告(1)恒瑞医药:获得药物临床试验批准通知书;(2)百利天恒:iza-bren用于治疗复发性或转移性食管鳞癌的药品上市申请获得...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.